A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
Completed
Joseph Eye Hospital
Phase 2
2002-11-01
Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped
countries due to a lack of antibiotic availability and affordability, among other reasons.
Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may
be an effective and affordable treatment for corneal ulcers, allowing preservation of sight
for those afflicted with this disease.
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
Completed
Kolokotrones Family Foundation
Phase 2
2002-11-01
Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped
countries due to a lack of antibiotic availability and affordability, among other reasons.
Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may
be an effective and affordable treatment for corneal ulcers, allowing preservation of sight
for those afflicted with this disease.
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
Completed
L.V. Prasad Eye Institute
Phase 2
2002-11-01
Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped
countries due to a lack of antibiotic availability and affordability, among other reasons.
Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may
be an effective and affordable treatment for corneal ulcers, allowing preservation of sight
for those afflicted with this disease.
A Clinical Trial of Povidone-Iodine for the Treatment of Bacterial Corneal Ulcers
Completed
Research to Prevent Blindness
Phase 2
2002-11-01
Bacterial corneal ulcers are a leading cause of pediatric blindness in underdeveloped
countries due to a lack of antibiotic availability and affordability, among other reasons.
Povidone-iodine, an inexpensive and readily available broad-spectrum antimicrobial agent, may
be an effective and affordable treatment for corneal ulcers, allowing preservation of sight
for those afflicted with this disease.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
